Can-Fite BioPharma Ltd. (CANF)
AMEX·Healthcare·Biotechnology
$2.25
+1.35%
Mkt Cap $2.20M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$8.00
Range $8.00 – $8.00
Implied Upside
+255.6%
Consensus $8.00 vs current $2.25
AMEX·Healthcare·Biotechnology
$2.25
+1.35%
Mkt Cap $2.20M
No recent rating data.
Price Target (4 analysts)
$8.00
Range $8.00 – $8.00
+255.6%
Consensus $8.00 vs current $2.25